Company Overview of D&A Pharma SAS
D&A Pharma SAS, a pharmaceutical company, engages in the research, development, production, and marketing of drugs to treat patients suffering from addictions, such as alcohol, heroin, and cocaine in France and internationally. It offers phyto-orogranules, a dry formulation in pellets with a very fast absorption in the mouth; and baume agathol, rocgel, calprimum, and trolovol. The company was founded in 2006 and is based in Paris, France.
79 rue de Miromesnil
Founded in 2006
33 1 53 04 41 30
33 1 42 94 20 18
Key Executives for D&A Pharma SAS
Similar Private Companies By Industry
|A.T.O. ZIZINE S.A.S||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact D&A Pharma SAS, please visit www.da-pharma.fr. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.